This article is freely available to all

ABSTRACT

Recent advances in technology can lead to earlier detection of Alzheimer disease (AD) in patients and therefore opportunities for early diagnosis and treatment. In addition, novel agents can slow disease progression and improve symptoms. However, clinicians are not providing a diagnosis to over half of individuals who meet criteria for dementia. Early detection and intervention are crucial to slow symptom progression, and these advances provide a window of opportunity to diagnose the disease early and even prevent it from becoming symptomatic. Clinicians need education on early recognition of AD and on sharing the diagnosis of AD with patients and families as well as guidance for providing patients and families with information on next steps and facilitating early treatment initiation for AD. Partnering with clinicians in the primary care setting and providing them with the necessary tools can change the trajectory of the disease for patients and caregivers. 

PDF version of article
Note: To read the entire article and receive credit, you must navigate through the entire online activity. Click link below.

Read the entire article

J Clin Psychiatry 2023;84(2):LI21019AH3C 

aBarrow Neurological Institute, Phoenix, Arizona
bBanner Sun Health Research Institute, Sun City, Arizona

To cite: Burke AD, Goldfarb D. Diagnosing and treating Alzheimer disease during the early stage. J Clin Psychiatry 2023;84(2):LI21019AH3C
To share: https://doi.org/10.4088/JCP.LI21019AH3C
© Copyright 2023 Physicians Postgraduate Press, Inc. 

CME LogoCME Logo

View Related Activity

Go to Activity
  1. Barrow Neurological Institute, Phoenix, Arizona
  2. Banner Sun Health Research Institute, Sun City, Arizona